Leica Biosystems

Leica Biosystems is a global leader in anatomic pathology solutions, focusing on cancer diagnostics and workflow technologies. Founded in 1872 and headquartered in Nussloch, Germany, the company operates as a subsidiary of Danaher Corporation. With facilities in the U.S., U.K., China, and India, Leica Biosystems emphasizes precision and efficiency in cancer detection, enabling over 1.6 million diagnoses weekly. The company offers a comprehensive range of products and services, including workflow solutions for sample preparation, staining, imaging, and reporting. Its digital pathology capabilities are enhanced by advanced scanners and software, developed through strategic acquisitions like Aperio. Leica Biosystems also collaborates with biopharma companies to create companion diagnostics and has expanded its offerings with multiplex staining and analysis services. The company serves pathology labs, research institutions, and healthcare providers worldwide, aiming to improve patient outcomes through innovative cancer diagnostic solutions.